Machine-Learning Based Model to Improve Insulin Bolus Calculation in Type 1 Diabetes Therapy
- 22 June 2020
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 68 (1), 247-255
- https://doi.org/10.1109/tbme.2020.3004031
Abstract
Objective: The aim of this work is to propose a new machine-learning based model to improve the calculation of mealtime insulin boluses (MIB) in type 1 diabetes (T1D) therapy using continuous glucose monitoring (CGM) data. Indeed, MIB is still often calculated with the standard formula (SF), which does not account for glucose rate-of-change (ROC), causing critical hypo/hyperglycemic episodes. Methods: Four candidate models for MIB calculation, based on multiple linear regression (MLR) and least absolute shrinkage and selection operator (LASSO) are developed. The proposed models are assessed in silico, using the UVa/Padova T1D simulator, in different mealtime scenarios and compared to the SF and three ROC-accounting variants proposed in the literature. An assessment on real data, by retrospectively analyzing 218 glycemic traces, is also performed. Results: All four tested models performed better than the existing techniques. LASSO regression with extended feature-set including quadratic terms LASSO_Q produced the best results. In silico, LASSO_Q reduced the error in estimating the optimal bolus to only 0.86U (1.45U of SF and 1.36-1.44U of literature methods), as well as hypoglycemia incidence (from 44.41% of SF and 44.60-45.01% of literature methods, to 35.93%). Results are confirmed by the retrospective application to real data. Conclusion: New models to improve MIB calculation accounting for CGM-ROC and easy-to-measure features can be developed within a machine learning framework. Particularly, in this paper, a new LASSO_Q model was developed which ensures better glycemic control than SF and other literature methods. Significance: MIB dosage with the proposed LASSO_Q model can potentially reduce the risk of adverse events in T1D therapy.Keywords
Funding Information
- Italian Minister for Education
- Dipartimenti di Eccellenza (232/2016)
This publication has 34 references indexed in Scilit:
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: OverviewDiabetes Care, 2013
- Continuous Glucose Monitoring: Current Use and Future DirectionsCurrent Diabetes Reports, 2013
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2012
- Collinearity: a review of methods to deal with it and a simulation study evaluating their performanceEcography, 2012
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010
- Statistical Tools to Analyze Continuous Glucose Monitor DataDiabetes Technology & Therapeutics, 2009
- Analysis of Guidelines for Basal-Bolus Insulin Dosing: Basal Insulin, Correction Factor, and Carbohydrate-To-Insulin RatioEndocrine Practice, 2008
- Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)Pediatric Diabetes, 2008
- A Bolus Calculator Is an Effective Means of Controlling Postprandial Glycemia in Patients on Insulin Pump TherapyDiabetes Technology & Therapeutics, 2003
- Hypoglycemia in DiabetesDiabetes Care, 2003